HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Castillo, U. F. Articles by Yaver, D. Search for Related Content PubMed PubMed Citation Articles by Castillo, U. F. Articles by Yaver, D. Agricola Articles by Castillo, U. F. Articles by Yaver, D.

Munumbicins, wide-spectrum antibiotics produced by Streptomyces NRRL 30562, endophytic on Kennedia nigriscans^a

Dept of Plant Sciences, Montana State University, Bozeman, MT 59717, USA¹
Dept of Botany and Range Sciences² and Dept of Microbiology³, Brigham Young University, Provo, UT 84602, USA
Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA⁴
Infectious Diseases Section, Veterans Affairs Medical Center, 500 West Fort St, Boise, ID 83702 and Dept of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA⁵
Novozymes Biotech Inc., 1445 Drew Ave, Davis, CA 95616, USA⁶

Author for correspondence: Gary Strobel. Tel: +1 406 994 5148. Fax: +1 406 994 7600. e-mail: uplgs{at}montana.edu

Munumbicins A, B, C and D are newly described antibiotics with a wide spectrum of activity against many human as well as plant pathogenic fungi and bacteria, and a Plasmodium sp. These compounds were obtained from Streptomyces NRRL 3052, which is endophytic in the medicinal plant snakevine (Kennedia nigriscans), native to the Northern Territory of Australia. This endophyte was cultured, the broth was extracted with an organic solvent and the contents of the residue were purified by bioassay-guided HPLC. The major components were four functionalized peptides with masses of 1269·6, 1298·5, 1312·5 and 1326·5 Da. Numerous other related compounds possessing bioactivity, with differing masses, were also present in the culture broth extract in lower quantities. With few exceptions, the peptide portion of each component contained only the common amino acids threonine, aspartic acid (or asparagine), glutamic acid (or glutamine), valine and proline, in varying ratios. The munumbicins possessed widely differing biological activities depending upon the target organism. For instance, munumbicin B had an MIC of 2·5 µg ml^-1 against a methicillin-resistant strain of Staphylococcus aureus, whereas munumbicin A was not active against this organism. In general, the munumbicins demonstrated activity against Gram-positive bacteria such as Bacillus anthracis and multidrug-resistant Mycobacterium tuberculosis. However, the most impressive biological activity of any of the munumbicins was that of munumbicin D against the malarial parasite Plasmodium falciparum, having an IC₅₀ of 4·5±0·07 ng ml^-1. This report also describes the potential of the munumbicins in medicine and agriculture.

Keywords: endophyte, actinomycete, malaria, tuberculosis, biological control

Abbreviations: COSY, correlated spectroscopy

^a The GenBank accession number for the sequence determined in this work is AY127079.

This article has been cited by other articles:

				S. Qin, J. Li, H.-H. Chen, G.-Z. Zhao, W.-Y. Zhu, C.-L. Jiang, L.-H. Xu, and W.-J. Li Isolation, Diversity, and Antimicrobial Activity of Rare Actinobacteria from Medicinal Plants of Tropical Rain Forests in Xishuangbanna, China Appl. Envir. Microbiol., October 1, 2009; 75(19): 6176 - 6186. [Abstract] [Full Text] [PDF]

				S. Compant, B. Duffy, J. Nowak, C. Clement, and E. A. Barka Use of Plant Growth-Promoting Bacteria for Biocontrol of Plant Diseases: Principles, Mechanisms of Action, and Future Prospects Appl. Envir. Microbiol., September 1, 2005; 71(9): 4951 - 4959. [Full Text] [PDF]

				D. Ezra, U. F. Castillo, G. A. Strobel, W. M. Hess, H. Porter, J. B. Jensen, M. A. M. Condron, D. B. Teplow, J. Sears, M. Maranta, et al. Coronamycins, peptide antibiotics produced by a verticillate Streptomyces sp. (MSU-2110) endophytic on Monstera sp. Microbiology, April 1, 2004; 150(4): 785 - 793. [Abstract] [Full Text] [PDF]

				G. Strobel and B. Daisy Bioprospecting for Microbial Endophytes and Their Natural Products Microbiol. Mol. Biol. Rev., December 1, 2003; 67(4): 491 - 502. [Abstract] [Full Text] [PDF]

				G. L. Challis and D. A. Hopwood Synergy and contingency as driving forces for the evolution of multiple secondary metabolite production by Streptomyces species PNAS, November 25, 2003; 100(suppl_2): 14555 - 14561. [Abstract] [Full Text]

				From the Library Br J Ophthalmol, March 1, 2003; 87(3): 378 - 378. [Full Text] [PDF]